Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01168024

Contrast Media Reduction and Removal in Patients With CKD (PRESERV)

Radiographic Contrast Agent Nephropathy Clinical Trial

Official title:
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial

Clinical Trial Summary

The purpose of this clinical trial is to demonstrate the efficacy and safety of the Osprey Medical CINCOR™ Contrast Removal System.

Clinical Trial Description

The CINCOR™ Catheter System to retrieve contrast media from the coronary sinus following injection during percutaneous coronary interventions. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

  • Radiographic Contrast Agent Nephropathy
Clinical Trial Details
NCT number NCT01168024
Study type Interventional
Source Osprey Medical, Inc
Contact
Status Terminated
Phase Phase 3
Start date December 2012
Completion date November 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT00540904 - Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate Phase 2
Recruiting NCT00584350 - Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Phase 4
Recruiting NCT01820195 - N-Acetyl Cystein and Contrast Nephropathy Phase 3
Completed NCT02137863 - Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy Phase 4
Completed NCT01866800 - The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI Phase 4
Active, not recruiting NCT01778140 - Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System N/A
Completed NCT02483143 - NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial Phase 4
Completed NCT01525888 - Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy N/A
Recruiting NCT02643706 - Relationship Between ALDH2 and CIN N/A
Completed NCT02643602 - Does Bicarbonate in Addition to Theophylline Reduce CIN? N/A
Recruiting NCT02029820 - RenalGuard System for Prevention of Contrast Induced Nephropathy Phase 3
Terminated NCT01654328 - Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy N/A